HNO International, Inc.
HNOI · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.02 | -2.75 |
| FCF Yield | -500.66% | -8,023.15% | -0.09% | -0.20% |
| EV / EBITDA | -3.59 | -3.61 | -703.54 | -410.70 |
| Quality | ||||
| ROIC | 1,204.47% | 209.41% | 237.89% | -633.62% |
| Gross Margin | 0.00% | 100.00% | 0.00% | 50.00% |
| Cash Conversion Ratio | 0.04 | 1.07 | 0.27 | 0.65 |
| Growth | ||||
| Revenue 3-Year CAGR | 49.81% | 54.40% | -48.05% | -45.27% |
| Free Cash Flow Growth | 58.90% | -45.16% | 26.10% | 18.89% |
| Safety | ||||
| Net Debt / EBITDA | -3.49 | -3.59 | -2.57 | -2.55 |
| Interest Coverage | -73.27 | -49.48 | -91.51 | -92.17 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -549.82 | -656.37 | -428.40 | -177.23 |